AstraZeneca axes Moderna-partnered phase 2 heart drug
Summer COVID boosters for people under 50 shelved in favor of update boosters in the fall
LabCorp plans to spinoff its $6B drug development biz
Novo Nordisk's once-weekly insulin marches on after hitting goals in pair of phase 3 trials
*please scroll down for all the latest news*
